Fat cell knee injection trial for Post-Trauma arthritis pulled before start

NCT ID NCT05515523

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This pilot trial aimed to test the safety and feasibility of a single injection of a patient's own fat-derived cells (stromal vascular fraction) into the knee for post-traumatic osteoarthritis. It was designed for adults aged 18–45 with a history of knee injury. However, the study was withdrawn before enrolling any participants, so no results are available.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
stromal vascular fraction (SVF) cells from the patient's own fat tissue
What this could lead to
If successful, this approach could point toward a way to reduce pain and improve knee function after injury-related arthritis, possibly delaying or avoiding joint replacement.
What could go wrong
This was a very early pilot trial (Phase 1) that was withdrawn before any participants were enrolled, so no safety or effectiveness data exist. The approach is still highly experimental and unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KNEE POST-TRAUMATIC OSTEOARTHRITIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina, 27157, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.